| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (NCT05182164) | Institut Bergonié | 2022-04-25 |
| A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor (NCT05275426) | Memorial Sloan Kettering Cancer Center | 2022-03-02 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors (NCT05302921) | Children's National Research Institute | 2022-02-18 |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) (NCT05266196) | Salarius Pharmaceuticals, LLC | 2022-01-15 |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (NCT04995003) | Baylor College of Medicine | 2021-12-07 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors (NCT04337177) | Valent Technologies, LLC | 2021-10-25 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
| Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma (NCT04735289) | Istituto Ortopedico Rizzoli | 2021-03-10 |
| Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (NCT04758000) | Istituto Ortopedico Rizzoli | 2021-03-01 |
| SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients (NCT04067115) | Sarcoma Alliance for Research through Collaboration | 2021-01-05 |
| Drug Sensitivity and Mutation Profiling (NCT04956198) | Florida International University | 2020-11-17 |
| Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma (NCT03880123) | Matthew Ingham | 2020-11-01 |
| Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma (NCT06851221) | Meyer Children's Hospital IRCCS | 2020-08-05 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (NCT04055220) | Centre Leon Berard | 2020-03-03 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (NCT03709680) | Pfizer | 2019-05-24 |
| Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas (NCT03478462) | Cellectar Biosciences, Inc. | 2019-04-30 |
| Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors (NCT03604783) | Sumitomo Pharma America, Inc. | 2018-12-26 |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas (NCT03715933) | Inhibrx Biosciences, Inc | 2018-10-08 |
| A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide (NCT03495921) | Gradalis, Inc. | 2018-08-21 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD (NCT06068075) | Dana-Farber Cancer Institute | 2018-05-08 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (NCT03458728) | Bayer | 2018-04-30 |
| Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) (NCT03441360) | Eisai Inc. | 2018-04-17 |
| Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors (NCT03245450) | Eisai Inc. | 2018-03-05 |
| Irinotecan and Temozolomide for Ewing Sarcoma (NCT03359005) | Peking University People's Hospital | 2018-02-07 |
| Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097) | Bambino Gesù Hospital and Research Institute | 2018-01-05 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers (NCT03190174) | Sarcoma Oncology Research Center, LLC | 2017-08-24 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NCT04308330) | New York Medical College | 2017-03-17 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors (NCT02581384) | Dana-Farber Cancer Institute | 2017-01-01 |
| Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors (NCT02982941) | MacroGenics | 2016-12-01 |
| Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (NCT02856048) | Assistance Publique - Hôpitaux de Paris | 2016-11-23 |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-25 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors (NCT02536183) | AeRang Kim | 2016-10-01 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (NCT02624388) | University of Virginia | 2016-08-01 |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (NCT02520128) | University College, London | 2016-03-01 |
| Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (NCT02508038) | University of Wisconsin, Madison | 2016-02-12 |
| Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas (NCT02409576) | National University Hospital, Singapore | 2015-02-01 |
| ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma (NCT02044120) | Sarcoma Alliance for Research through Collaboration | 2014-05-01 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors (NCT02076906) | AeRang Kim | 2014-04-01 |
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors (NCT02013336) | South Plains Oncology Consortium | 2013-12-01 |
| Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma (NCT01858168) | Massachusetts General Hospital | 2013-07-01 |
| Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors (NCT01807468) | Samsung Medical Center | 2013-05-01 |
| A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma (NCT01969942) | University of Louisville | 2013-04-01 |
| Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors (NCT02100891) | Monica Thakar | 2013-03-20 |
| Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma (NCT01882231) | Vanderbilt-Ingram Cancer Center | 2013-03-01 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas (NCT01625351) | St. Jude Children's Research Hospital | 2012-08-20 |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma (NCT01610570) | National Cancer Institute (NCI) | 2012-05-10 |
| Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting (NCT01492569) | Stanford University | 2012-05-01 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931) | Timothy Cripe | 2010-03-01 |
| Methionine PET/CT Studies In Patients With Cancer (NCT00840047) | St. Jude Children's Research Hospital | 2009-07-20 |
| Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults (NCT01780779) | Universitaire Ziekenhuizen KU Leuven | 2009-06-01 |
| A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma (NCT00743496) | St. Jude Children's Research Hospital | 2008-10-08 |
| Evaluating Dactinomycin and Vincristine in Young Patients With Cancer (NCT00674193) | Children's Oncology Group | 2008-02-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Machine Learning Applied to EHRs Data of Patients With Sarcoma (NCT07215728) | University of Milano Bicocca | 2003-01-01 |
| Eligibility Screening for a NCI Pediatric Oncology Branch Research Study (NCT00026780) | National Cancer Institute (NCI) | 2001-09-24 |
| The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma (NCT06659224) | asmaa salama ibrahim | 2000-01-01 |
| Expanded Access of Vigil in Solid Tumors (NCT03842865) | Gradalis, Inc. | |
| Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma (NCT03029481) | Jonsson Comprehensive Cancer Center | |